PUBLISHER: The Business Research Company | PRODUCT CODE: 1994777
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994777
Smart tissue autonomous robot (STAR) is a surgical robotics innovation developed to automate soft-tissue procedures through advanced imaging systems, autonomous stitching algorithms, real-time tissue monitoring, and robotic control technologies. It combines sensors, computer vision, force feedback mechanisms, and AI-driven decision tools to improve precision, minimize human error, and enhance surgical results in soft-tissue operations. This technology supports higher procedural accuracy, consistent outcomes, and minimally invasive surgical techniques.
The key components of the smart tissue autonomous robot (STAR) include hardware and software. Hardware refers to the physical robotic systems, surgical instruments, sensors, and control units that enable autonomous or semi-autonomous surgical procedures. These solutions are designed for various surgical techniques, including open surgery, minimally invasive surgery, and endoscopic surgery, and leverage technologies such as artificial intelligence, machine learning, computer vision, and robotic manipulation. They are applied across multiple procedures, including soft tissue surgery, plastic and reconstructive surgery, orthopedic surgery, gastrointestinal surgery, and cardiothoracic surgery, and serve diverse end-users such as hospitals, ambulatory surgical centers, research institutions, and clinics.
Tariffs are impacting the smart tissue autonomous robot market by increasing the cost of imported robotic components, surgical sensors, imaging modules, and control electronics. Higher duties on precision mechatronic parts are raising system prices for hospitals and surgical centers. Regions dependent on imported surgical robotics hardware face budget pressure and slower adoption. Advanced imaging and force sensing modules are more exposed due to high component value. Software driven capabilities are less directly affected by tariffs. At the same time, tariffs are encouraging localized medical robotics manufacturing and assembly. This supports regional device makers and integration partners.
The smart tissue autonomous robot (star) market research report is one of a series of new reports from The Business Research Company that provides smart tissue autonomous robot (star) market statistics, including smart tissue autonomous robot (star) industry global market size, regional shares, competitors with a smart tissue autonomous robot (star) market share, detailed smart tissue autonomous robot (star) market segments, market trends and opportunities, and any further data you may need to thrive in the smart tissue autonomous robot (star) industry. This smart tissue autonomous robot (star) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The smart tissue autonomous robot (star) market size has grown exponentially in recent years. It will grow from $0.3 billion in 2025 to $0.36 billion in 2026 at a compound annual growth rate (CAGR) of 20.3%. The growth in the historic period can be attributed to growth in robotic surgery platforms, minimally invasive surgery demand, surgical imaging advances, hospital robotics investments, precision surgery requirements.
The smart tissue autonomous robot (star) market size is expected to see exponential growth in the next few years. It will grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to autonomous surgery research expansion, AI surgical workflow integration, advanced sensing instrument demand, reproducible surgery outcomes focus, next generation surgical robotics funding. Major trends in the forecast period include autonomous soft tissue suturing systems, AI guided surgical decision engines, real time tissue tracking robotics, force feedback surgical instruments, image driven robotic navigation.
The rising demand for minimally invasive surgical procedures is anticipated to propel the growth of the smart tissue autonomous robot (STAR) market in the coming years. Minimally invasive surgical procedures involve performing operations through small incisions or natural body openings using specialized instruments to minimize tissue trauma, reduce blood loss, and accelerate recovery timelines while maintaining high surgical accuracy. The increasing adoption of minimally invasive surgical procedures is largely attributed to improved patient safety outcomes. The smart tissue autonomous robot (STAR) supports the growing demand for minimally invasive surgical procedures by precisely executing complex soft-tissue surgeries through limited access points, reducing the likelihood of human error, limiting tissue damage, and improving overall surgical accuracy and patient recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, hyaluronic acid filler minimally invasive procedures reached 5.29 million in 2023, representing an 8% increase compared to 2022. Therefore, the increasing demand for minimally invasive surgical procedures is contributing to the growth of the smart tissue autonomous robot (STAR) market.
The growing investments by hospitals in robotic infrastructure are anticipated to propel the growth of the smart tissue autonomous robot (STAR) market going forward. Robotic infrastructure encompasses the integration of robotic systems along with the associated software, hardware, and facilities required to effectively deploy, operate, and maintain robotic technologies within healthcare organizations. The increase in hospital investments in robotic infrastructure is driven by the need to enhance surgical precision. The smart tissue autonomous robot (STAR) supports expanding hospital investments in robotic infrastructure by delivering an advanced autonomous surgical solution that combines artificial intelligence, imaging technologies, and precision robotics, enabling hospitals to strengthen surgical performance, improve clinical outcomes, and optimize returns on robotic technology investments. For instance, in November 2025, according to Springer Nature, a Germany-based academic and scientific publishing company, surgical robot ownership among trusts increased by 42% from 36 to 51, with usage expanding to 49 trusts for general surgery and doubling for emergency procedures from 13 to 26 trusts. Therefore, the expanding hospital investments in robotic infrastructure are supporting the growth of the smart tissue autonomous robot (STAR) market.
The shortage of skilled surgeons is expected to propel the growth of the smart tissue autonomous robot (STAR) market in the forecast period. Skilled surgeons are qualified and experienced medical professionals with specialized training and expertise required to accurately perform surgical procedures, manage complications, and ensure patient safety. The shortage of skilled surgeons is primarily driven by rising retirement rates. The smart tissue autonomous robot (STAR) addresses the shortage of skilled surgeons by autonomously executing complex soft-tissue procedures with high precision, reducing reliance on continuous human expertise and enabling surgical teams to sustain efficiency and consistency amid workforce limitations. For instance, in April 2024, according to the American Association of Neurological Surgeons (AANS), a leading US-based scientific and educational association, projections indicated that the United States could face a physician shortage of up to 86,000 by 2036. Therefore, the shortage of skilled surgeons is driving the growth of the smart tissue autonomous robot (STAR) market.
Major companies operating in the smart tissue autonomous robot (star) market are Johnson & Johnson, Medtronic, ABB Ltd, Siemens Healthineers, Stryker Corporation, Philips, Boston Scientific, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Smith & Nephew plc, KARL STORZ, Globus Medical, Inc., Renishaw plc, CMR Surgical Limited, Osso VR, Caresyntax, Think Surgical, Inc, Activ Surgical, Tuodao Medical, Sina Robotics & Medical Innovators Co
North America was the largest region in the smart tissue autonomous robot (STAR) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart tissue autonomous robot (star) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the smart tissue autonomous robot (star) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The smart tissue autonomous robot (STAR) market consists of sales of robotic surgical systems, autonomous suturing devices, 3D imaging and navigation modules, force-sensing instruments, AI-driven control software, and real-time tissue monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Smart Tissue Autonomous Robot (STAR) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses smart tissue autonomous robot (star) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for smart tissue autonomous robot (star) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart tissue autonomous robot (star) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.